Group synergies coming through

Hardman & Co

Hardman & Co Report Report Downloads1pm Plc (LON:OPM) The FY’18 results delivered exactly what management promised. Loan origination was up 72%, revenue rose 78%, pre-tax profits increased 93%, while EPS grew 24%. The synergies from being a bigger group are emerging. Funding costs have fallen rapidly. Perhaps of greater importance, cross-group sales leads were £13m in 4Q FY’18. Not all will convert, but this represents nearly 10% of FY’18 origination. While we note a retiring director’s 6% stake may be viewed as a stock overhang, the implied May 2019 P/E of 6.7x and price to book of 0.9x, appears an anomaly given the downside risk highlighted in our sensitivity analyses.

FY’18 results: These results confirm all the company promises. Strong franchise growth has been delivered. Provisioning continues to be conservative (“general” provisions are over a third of the charge). Our updated credit sensitivity scenario (detailed below) indicates 2020E EPS above 2017, even in a hard landing.

Outlook: We have continued to accelerate investment into 2019 and this has led to a 2% trimming of EPS estimates for that year. We have introduced 2020 estimates showing further double-digit EPS growth. 1pm has previously announced an intent to increase dividend by 30% p.a. to FY’21.

Risks: Credit risk is a key factor and is managed by each business unit according to its own specific characteristics, with a group overview of controls. Funding is widely diversified and at least matches the duration of lending. Acquisitions would appear well priced and delivery of synergies provides earnings upside.

Valuation: We detailed the assumptions in our valuation approaches in our initiation note, “Financing powerhouse: A lunchtime treat”. The GGM indicates 116p and the DDM 70p (DDM normal payout 78p). The 2020E P/E (6.7x) and P/B (0.9x) appear an anomaly with 1pm’s profitability, growth and downside risk.

Investment summary: 1pm Plc offers strong earnings growth, in an attractive market, where management is tightly controlling risk. Targets to more than double the market capitalisation appear credible, with triggers to a re-rating being both fundamental (delivery of earnings growth, proof of cross-selling) and sentiment-driven (payback for management actively engaging the investor community). Profitable, growing companies generally trade well above NAV.

Share on:

Latest Company News

Diversified Energy gains recognition for sustainability focus

Diversified Energy shortlisted for US IR award recognising ESG alignment and responsible investor engagement.

Dunelm reports solid H1 FY26 sales growth amid challenging market conditions

Dunelm Group plc announced Interim Results for the 26 weeks to 27 December 2025, reporting total sales growth of 3.6% to £926.3m and increased market share despite a softer second quarter.

Bellway reports higher completions and maintains FY26 guidance

Bellway said first-half housing completions rose to 4,702 homes, with revenue up over 6% to £1.51bn, despite softer reservation rates through the autumn.

Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)

Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world use—and why clinicians and payers are getting on board.

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International.

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress.

    Search

    Search